Cargando…

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma

We sought to identify a serum miRNA expression profile to improve disease surveillance and to predict post-operative disease recurrence for stage II/III colorectal cancer (CRC) patients. Using the TaqMan Low-Density Array (TLDA), we performed an initial survey to analyze 749 miRNAs in the pooled ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jialu, Liu, Yang, Wang, Cheng, Deng, Ting, Liang, Hongwei, Wang, Yifei, Huang, Dingzhi, Fan, Qian, Wang, Xia, Ning, Tao, Liu, Rui, Zhang, Chen-Yu, Zen, Ke, Chen, Xi, Ba, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528229/ https://www.ncbi.nlm.nih.gov/pubmed/26250939 http://dx.doi.org/10.1038/srep12921

Ejemplares similares

A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma
por: Wang, Cheng, et al.
Publicado: (2015)

miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer
por: Li, Jialu, et al.
Publicado: (2015)

Correction: miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer
por: Li, Jialu, et al.
Publicado: (2015)

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
por: Han, Jiayi, et al.
Publicado: (2020)

Diagnostic and Prognostic Implications of a Serum miRNA Panel in Oesophageal Squamous Cell Carcinoma
por: Wu, Caiyun, et al.
Publicado: (2014)

Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer
por: Feng, Junlan, et al.
Publicado: (2021)

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma
por: Wang, Cheng, et al.
Publicado: (2021)

The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
por: You, Weiqiang, et al.
Publicado: (2019)

Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
por: Zhang, Tian, et al.
Publicado: (2017)

Prognostic Significance and Gene Expression Profiles of p53 Mutations in Microsatellite-Stable Stage III Colorectal Adenocarcinomas
por: Katkoori, Venkat R., et al.
Publicado: (2012)

Prognostic value of the lymph node ratio in stage III colorectal cancer
por: Ren, Jing-Qing, et al.
Publicado: (2012)

Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis
por: Du, Qingwu, et al.
Publicado: (2023)

Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection
por: Ke, Bin, et al.
Publicado: (2014)

Deregulation of the miR-16-KRAS axis promotes colorectal cancer
por: You, Chaoying, et al.
Publicado: (2016)

Necrosis score as a prognostic factor in stage I–III colorectal cancer: a retrospective multicenter study
por: Ye, Huifen, et al.
Publicado: (2023)

miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer
por: Yan, Xin, et al.
Publicado: (2014)

The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer—A retrospective cohort study
por: Tong, Guojun, et al.
Publicado: (2018)

Author Correction: Deregulation of the miR-16-KRAS axis promotes colorectal cancer
por: You, Chaoying, et al.
Publicado: (2021)

Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal cancer
por: Feng, Shouhan, et al.
Publicado: (2023)

A 5-serum miRNA panel for the early detection of colorectal cancer
por: Guo, Shaohua, et al.
Publicado: (2018)

Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Su, Qiang, et al.
Publicado: (2018)

Nomograms incorporated serum direct bilirubin level for predicting prognosis in stages II and III colorectal cancer after radical resection
por: Zhang, Qunfeng, et al.
Publicado: (2016)

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma
por: Yang, Qi-Fan, et al.
Publicado: (2021)

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer
por: Yu, Tong, et al.
Publicado: (2021)

Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease
por: Dong, Hui, et al.
Publicado: (2015)

Expression and prognosis of inducible T‐cell co‐stimulator and its ligand in Chinese stage I–III lung adenocarcinoma patients
por: Zhan, Xiao‐Kai, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
por: Wang, Dingzhi, et al.
Publicado: (2008)

Prognostic significance of high triglyceride and apolipoprotein B levels in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery
por: Chen, Xiu-Qing, et al.
Publicado: (2020)

Differences in oncological outcomes and inflammatory biomarkers between right‐sided and left‐sided stage I‐III colorectal adenocarcinoma
por: Guo, Dongming, et al.
Publicado: (2019)

Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2022)

Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma
por: Sun, Ke, et al.
Publicado: (2019)

Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma
por: Huang, Lin, et al.
Publicado: (2020)

Distinct expression profile of HCMV encoded miRNAs in plasma from oral lichen planus patients
por: Ding, Meng, et al.
Publicado: (2017)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer
por: Sun, Wu, et al.
Publicado: (2020)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Investigating potential molecular mechanisms of serum exosomal miRNAs in colorectal cancer based on bioinformatics analysis
por: Wang, Haifeng, et al.
Publicado: (2020)

Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients
por: Cheng, Xiankui, et al.
Publicado: (2018)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sv4jl6a8acqpkeq9b5qjho115n